The FDA has approved the use of the Pzifer-Biontech covid vaccine in youngsters aged 12-15, reports NBC News.
The two-dose vaccine is already authorized for use in people 16 and older. The Centers for Disease Control and Prevention's vaccine advisory committee has scheduled a meeting Wednesday to review the shots for kids. If approved by the CDC as expected, it could be distributed to adolescents as soon as this week.